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| INTRODUC TI ON
Brain metastases are devastating complications of lung or breast carcinoma, melanoma and other cancer types, characterized by challenging treatment options. 1, 2 Melanoma is the third most common source of brain metastases, 3 but has the highest risk to spread into the central nervous system (CNS). 4 Brain metastatic lesions can be found in approximately three of four patients dying of melanoma. 5 Breast cancer is the second most frequent cause of CNS metastases. 3 Among different subtypes, triple negative (ie negative for estrogen and progesterone hormone receptors and also for Her2/human epidermal growth factor receptor 2) and Her2-enriched (ie negative for hormone receptors and positive for Her2) mammary tumours are the most prone to give secondary brain tumours. 6 Incidence proportion of brain metastases was found to be 11.37% and 11.45% in patients having metastatic triple negative or metastatic Her2-enriched breast tumours, respectively. 7 In brain metastatic melanoma, novel systemic targeted therapies and immunotherapies significantly increased the median overall survival of the patients; however, it is still below 2 years. 8, 9 Among patients with breast cancer brain metastasis, the median overall survival time was reported to be 6 months for the triple negative subtype and 10 months for the Her2-enriched subtype. By using high resolution transmission electron microscopy (TEM),
here we aimed to investigate the transmigration routes of melanoma and triple negative breast cancer cells through brain endothelial cells. In addition, involvement of N-cadherin in these processes was also assessed. 
| MATERIAL AND ME THODS

| Cell culture and in vitro models
| In vivo brain metastasis models
| Preparation of ultrasections and transmission electron microscopy (TEM)
Whole brains were embedded in 10% gelatin and 100 μm sections were prepared using a Leica VT1000 S vibratome. Sections were examined under a fluorescence microscope. Sections containing EmGFP-4T1 cells were further used.
The filter inserts or the selected brain slices were fixed for 2.5 hours in 2.7% glutaraldehyde and post-fixed for 75 minutes in 2% osmium tetroxide. After dehydration in graded ethanol baths, the samples were immersed in graded ethanol-Epon baths and then embedded in Epon 812. The blocks were cut with a Leica EM UC7 ultramicrotome, and the 50 nm thick sections were stained with uranyl acetate and lead citrate, then analysed with a Tecnai 12 Biotwin TEM.
| Immunofluorescence and fluorescence microscopy
Cell Brain sections were placed in plates and subjected to antigen retrieval using 100% methanol for 30 minutes. Permeabilization was performed with 0.5% TritonX-100 for 30 minutes at room temperature, followed by blocking with 3% BSA in PBS. The first antibody was applied in a dilution of 1:100 in 1% BSA overnight at 4°C. After washing in PBS, the secondary antibody (STAR RED anti-mouse IgG; Abberior, Göttingen, Germany) was applied in a dilution of 1:500 in PBS for 1 hour at room temperature.
After three further washing steps, samples were mounted with was used for the quantification of the blots by densitometry.
| Real-time impedance monitoring
To monitor the effects of tumour cells on RBECs in real time,
we measured the electrical impedance using the xCELLi- Figure 2C ) or, more often, were seen in the neighbourhood of the damaged endothelial cells ( Figure 2D ).
| Interactions of breast cancer cells with brain endothelial cells in vitro
Similar to melanoma cells, we could also identify breast cancer cells attached to cerebral endothelial junctions ( Figure 3A and B), although less in number. In the proximity of these cells, filopodia-like endothelial protrusions could be seen, similar to those observed in the vicinity of melanoma cells.
We have also detected several breast cancer cells completely 
| Interactions of breast cancer cells with the brain endothelium in vivo
Finally, we examined interactions of metastatic breast cancer cells with the brain endothelium in vivo using TEM. In the brain sections obtained from mice injected with breast carcinoma cells, we observed active involvement of CECs in the metastatic extravasation process. Endothelial protrusions covering extravasating cancer cells were seen ( Figure 7A and B).
| D ISCUSS I ON
Development of brain metastases is largely dependent on the abil- To our best knowledge, we are the first to show direct evidence of transcellular migration of tumour cells through the BBB.
The transcellular route of migration has initially been recognized for leukocytes, 28 especially in the brain microvasculature. 29, 30 As for tumour cells, the transcellular route of migration has only 
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